TWA
COGT icon

TCI Wealth Advisors’s Cogent Biosciences COGT Stock Holding History

TCI Wealth Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-431
Closed -$4.65K – 625
2023
Q1 		$4.65K Buy
431
+139
+48% +$1.78K ﹤0.01% 1580
2022
Q4 		$3.38K Buy
292
+268
+1,117% +$3.32K ﹤0.01% 1790
2022
Q3 		$0 Buy
+24
New +$329 ﹤0.01% 2296

Other funds holding COGT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCI Wealth Advisors's COGT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Cogent Biosciences (COGT) in Q2 2023, closing a stake of 431 shares — an estimated $4.65K sold.

TCI Wealth Advisors first reported a position in COGT in Q3 2022 and held it in 3 quarters. The position peaked at $4.65K in Q1 2023. 136 funds tracked by Wall St. Rank hold COGT as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Cogent Biosciences position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 431 Cogent Biosciences shares in Q2 2023, an estimated $4.65K.
  • TCI Wealth Advisors first reported a position in Cogent Biosciences in Q3 2022 and held it in 3 quarters.
  • TCI Wealth Advisors's Cogent Biosciences position peaked at $4.65K in Q1 2023.
  • 136 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.